tiprankstipranks
Analyst Profile
Followed by 438 other investors
.
Jeff Johnson

Jeff Johnson

Robert W. Baird
Wall Street Analyst
Ranked #311 out of 8,014 Analysts on TipRanks (#418 out of 21,455 overall experts)

Success Rate

55%
133 out of 241 Profitable Transactions

Average Return

18.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Jeff Johnson's ratings since 2010 and opened each position for the duration of 1 Year:
55.19% of your transactions would have been profitable with an average return of 18.8%

Stock Rating Distribution

433Ratings
62.82% Buy
37.18% Hold
0.00% Sell
Distribution of Jeff Johnson's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Tandem Diabetes Care
(TNDM)
Rating Type:Buy
Dates:Mar 23, 2018 - Sep 14, 2018
Gain:800.00%
The most profitable rating made by Jeff Johnson

Jeff Johnson's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Young Innovations
Buy
Upgraded
100%
+10.30%
1
Sirona Dental
Buy
Upgraded
100%
+22.35%
2
Lantheus
Hold
Reiterated
0.00%
1
Exactech
Hold
Reiterated
100%
+21.43%
6
Wright Medical Group, Inc.
Hold
Downgraded
0.00%
1
Wright Medical Group
Hold
Downgraded
63%
+18.81%
10
Varian Medical Systems
Hold
Downgraded
100%
+41.40%
9
Cooper Co
Hold
Reiterated
$392.00
(18.31% Upside)
87%
+18.69%
34
Patterson Companies
Hold
Reiterated
$35.00
(13.34% Upside)
0%
-27.36%
32
Align Tech
Buy
Assigned
$410.00
(42.04% Upside)
60%
+21.19%
47
List of latest recommendations made by Jeff Johnson. Click to expand and see Jeff Johnson's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More